AbbVie to acquire cancer drug maker Pharmacyclics in $21bn deal
US-based biopharmaceutical firm AbbVie announced Wednesday that it has agreed to acquire Pharmacyclics Inc for about $21...
US-based biopharmaceutical firm AbbVie announced Wednesday that it has agreed to acquire Pharmacyclics Inc for about $21...